1. Home
  2. INKT vs ENLV Comparison

INKT vs ENLV Comparison

Compare INKT & ENLV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INKT
  • ENLV
  • Stock Information
  • Founded
  • INKT 2017
  • ENLV 2005
  • Country
  • INKT United States
  • ENLV Israel
  • Employees
  • INKT N/A
  • ENLV N/A
  • Industry
  • INKT Medicinal Chemicals and Botanical Products
  • ENLV Biotechnology: Pharmaceutical Preparations
  • Sector
  • INKT Health Care
  • ENLV Health Care
  • Exchange
  • INKT Nasdaq
  • ENLV Nasdaq
  • Market Cap
  • INKT 28.9M
  • ENLV 23.7M
  • IPO Year
  • INKT 2021
  • ENLV 1995
  • Fundamental
  • Price
  • INKT $7.39
  • ENLV $1.18
  • Analyst Decision
  • INKT Strong Buy
  • ENLV Strong Buy
  • Analyst Count
  • INKT 2
  • ENLV 2
  • Target Price
  • INKT $37.50
  • ENLV $10.00
  • AVG Volume (30 Days)
  • INKT 15.0K
  • ENLV 86.1K
  • Earning Date
  • INKT 08-12-2025
  • ENLV 05-30-2025
  • Dividend Yield
  • INKT N/A
  • ENLV N/A
  • EPS Growth
  • INKT N/A
  • ENLV N/A
  • EPS
  • INKT N/A
  • ENLV N/A
  • Revenue
  • INKT N/A
  • ENLV N/A
  • Revenue This Year
  • INKT N/A
  • ENLV N/A
  • Revenue Next Year
  • INKT N/A
  • ENLV N/A
  • P/E Ratio
  • INKT N/A
  • ENLV N/A
  • Revenue Growth
  • INKT N/A
  • ENLV N/A
  • 52 Week Low
  • INKT $4.56
  • ENLV $0.81
  • 52 Week High
  • INKT $13.79
  • ENLV $1.76
  • Technical
  • Relative Strength Index (RSI)
  • INKT 50.22
  • ENLV 69.48
  • Support Level
  • INKT $6.98
  • ENLV $0.90
  • Resistance Level
  • INKT $8.38
  • ENLV $1.30
  • Average True Range (ATR)
  • INKT 0.30
  • ENLV 0.08
  • MACD
  • INKT -0.00
  • ENLV 0.03
  • Stochastic Oscillator
  • INKT 32.41
  • ENLV 77.50

About INKT MiNK Therapeutics Inc.

MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering the discovery, development, and commercialization of allogeneic invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. The company is advancing a pipeline of both native and next generation engineered iNKT programs, with a platform designed to facilitate scalable and reproducible manufacturing for off-the-shelf delivery.

About ENLV Enlivex Therapeutics Ltd.

Enlivex Therapeutics Ltd is an Israel-based development-stage biopharmaceutical company. It is focused on developing and commercializing an allogeneic drug pipeline for rebalancing immune hyper-responses. The company's Allocetra is an immunotherapy that is being developed to rebalance a life-threatening unbalanced immune system, using the immune system's own natural regulation mechanisms.

Share on Social Networks: